FlowSense Sensor for Checking Fluid Flow in Hydrocephalus Shunts
Tests a wearable neck sensor measuring shunt fluid flow in children with hydrocephalus.
Key facts
- Who runs it
- Baylor College of Medicine
- Where
- Houston, United StatesSee the site
- Trial code
- Registry title
- EVD Drainage Data and Intracranial Pressure (ICP) Measurements
- Status
- Recruiting
- People taking part
- 24 people, planned
- Started
- 11 Jul 2023
- Expected to end
- 30 Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- FlowSense
- Record updated
- 25 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people with hydrocephalus who already have one or more external ventricular drains (EVDs), tubes that drain fluid from the brain. It tests a wireless skin sensor called FlowSense.
- Age
- 1 Year to 21 Years
- Sex
- All sexes can join.
- Disease stage
- Hydrocephalus, a build-up of fluid in the brain.
- Earlier treatment
- People must already have one or more external ventricular drains (EVDs) in place.
Main reasons for not taking part
- People with no external ventricular drain (EVD) cannot join.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patients with one or more existing external ventricular drains (EVDs)
Who cannot take part
- Patients with no external ventricular drains (EVDs)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 1 and 21 years old?
Where in United States
- Texas Children's HospitalHouston, United StatesContact: Sarah Martinez, MPHTaking people
About the trial
What the trial wants to find out
Rhaeos, Inc. is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.
Read full original descriptionShow less
FlowSense, is a wireless, noninvasive thermal flow sensor that can be mounted on a patient's neck overlying the shunt to detect the presence and magnitude of CSF. Similar in size to a bandage, it is composed of soft, silicone with no hard edges. Data is wirelessly transmitted to a custom designed mobile app. With FlowSense, monitoring of shunt function can occur in clinics, in-patient settings, and emergency departments, thereby reducing unnecessary imaging, hospital length of stay, and readmission costs.
The 2 groups in the trial
- Phase A:No study treatment, for comparison
Establish suitability of digital video recording system for quantifying CSF drainage into an EVD drainage system.
- Phase BOther group
Exploratory study to generate initial data on the correlation between FlowSense flow rate measurements (FlowSense Flow Rate) and: A) EVD drainage data, quantified via video recording; B) intracranial pressure (ICP) measurements
Treatment: FlowSense
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Correlation Between FlowSense Flow Rate Measurements and: EVD Drainage Data and Intracranial Pressure (ICP) Measurements
- Plain-language title
- FlowSense Sensor for Checking Fluid Flow in Hydrocephalus ShuntsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05546996, who can take part
- Record updated
- 25 March 2026